Tezcat Biosciences Overview

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1.11M

  • Investors
  • 10

Tezcat Biosciences General Information

Description

Developer of a drug delivery technology designed to target and treat aggressive diseases using receptor-independent mechanisms. The company offers macropinocytosis-based delivery, site-specific conjugation, and scalable manufacturing capabilities, enabling biotechnology researchers and pharmaceutical developers to create safe and effective therapeutics for hard-to-treat cancers and other complex diseases.

Contact Information

Website
www.tezcat.co
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 180 Varick Street
  • Floor 6
  • New York, NY 10014
  • United States
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Biotechnology
Vertical(s)
Corporate Office
  • 180 Varick Street
  • Floor 6
  • New York, NY 10014
  • United States

Tezcat Biosciences Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tezcat Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Grant 21-Aug-2025 $1.11M Completed Startup
12. Grant 29-Jul-2024 Completed Startup
11. Accelerator/Incubator 13-Oct-2023 Completed Startup
10. Grant 01-Jul-2023 Completed Startup
9. Accelerator/Incubator 01-Jan-2023 Completed Startup
8. Accelerator/Incubator 01-Jan-2023 Completed Startup
7. Grant 01-Sep-2021 Completed Startup
6. Accelerator/Incubator 26-Jan-2021 Completed Startup
5. Accelerator/Incubator 01-Jan-2021 Completed Startup
4. Grant 15-Jul-2020 $400K Completed Startup
To view Tezcat Biosciences’s complete valuation and funding history, request access »

Tezcat Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tezcat Biosciences Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
Endless Frontier Labs Accelerator/Incubator
MassBio Accelerator/Incubator
Start-up NY Accelerator/Incubator
Texas Medical Center Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Tezcat Biosciences FAQs

  • Where is Tezcat Biosciences headquartered?

    Tezcat Biosciences is headquartered in New York, NY.

  • What is the size of Tezcat Biosciences?

    Tezcat Biosciences has 6 total employees.

  • What industry is Tezcat Biosciences in?

    Tezcat Biosciences’s primary industry is Drug Delivery.

  • Is Tezcat Biosciences a private or public company?

    Tezcat Biosciences is a Private company.

  • What is Tezcat Biosciences’s current revenue?

    The current revenue for Tezcat Biosciences is .

  • Who are Tezcat Biosciences’s investors?

    National Institutes of Health, Endless Frontier Labs, MassBio, Start-up NY, and Texas Medical Center are 5 of 10 investors who have invested in Tezcat Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process